🇺🇸 FDA
Patent

US 12325752

Immunoglobulin proteins that bind to NPR1 agonists

granted A61KA61K2039/505A61K2039/54

Quick answer

US patent 12325752 (Immunoglobulin proteins that bind to NPR1 agonists) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Jun 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
44
CPC classes
A61K, A61K2039/505, A61K2039/54, A61K31/165, A61P